Literature DB >> 8613360

Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway.

M F Lopes1, G A DosReis.   

Abstract

In a model of experimental Chagas' disease induced with metacyclic forms of Trypanosoma cruzi, CD4+ but not CD8+ T cells undergo T-cell receptor (TCR)-CD3-mediated activation-induced cell death (AICD) in vitro. CD4+ T cells from T. cruzi-infected mice also developed unresponsiveness in proliferative responses to TCR-CD3-mediated stimulation. A linear correlation was found between extent of proliferative unresponsiveness and loss of CD4+ T-cell viability. CD4+ T-cell activation through the CD69 or Ly-6 A/E pathway, on the other hand, did not result in proliferative unresponsiveness compared with controls. Lack of suppression in proliferation assays correlated with lack of AICD by cells stimulated through the CD69 or Ly-6 A/E pathway. Concomitant stimulation through CD69, however, did not rescue CD4+ T cells from CD3-induced death. Flow cytometry study of cells stimulated in vitro showed no defect in interleukin-2 receptor expression by CD4+ T cells from infected donors, which escaped TCR-mediated AICD. In vivo injection of anti-CD3 into acutely infected mice, but not into control mice, led to splenocyte DNA fragmentation and failed to increase splenic CD4+ T-cell numbers. These results show that TCR-CD3-mediated AICD is involved in CD4+ T-cell unresponsiveness in vitro following infection with T. cruzi. In addition, successful activation of these cells through the CD69 and Ly-6 pathways is due to differences in the inability of these stimuli to trigger AICD. Since TCR-CD3-mediated AICD can be induced in vivo in infected mice, these findings may be relevant for the onset of immunological disturbances in the host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613360      PMCID: PMC173961          DOI: 10.1128/iai.64.5.1559-1564.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses.

Authors:  P M Minoprio; H Eisen; L Forni; M R D'Imperio Lima; M Joskowicz; A Coutinho
Journal:  Scand J Immunol       Date:  1986-12       Impact factor: 3.487

2.  Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells.

Authors:  R L Tarleton
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

3.  On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.

Authors:  F Kierszenbaum
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

4.  Trypanosoma cruzi: immunosuppressed response to different antigens in the infected mouse.

Authors:  C Ramos; E Lamoyi; M Feoli; M Rodriguez; M Perez; L Ortiz-Ortiz
Journal:  Exp Parasitol       Date:  1978-08       Impact factor: 2.011

5.  Acquired cell-mediated immunodepression in acute Chagas' disease.

Authors:  A R Teixeira; G Teixeira; V Macêdo; A Prata
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

6.  Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.

Authors:  R L Tarleton; R E Kuhn
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2.

Authors:  S G Reed; J A Inverso; S B Roters
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

8.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

Authors:  M J Lenardo
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

9.  CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.

Authors:  A Moretta; A Poggi; D Pende; G Tripodi; A M Orengo; N Pella; R Augugliaro; C Bottino; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.

Authors:  A N Akbar; N Borthwick; M Salmon; W Gombert; M Bofill; N Shamsadeen; D Pilling; S Pett; J E Grundy; G Janossy
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.

Authors:  Mustapha Chamekh; Vincent Vercruysse; Mohammed Habib; Maxime Lorent; Michel Goldman; Abdelmounaïm Allaoui; Bernard Vray
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection.

Authors:  Bianca Perdigão Olivieri; Vinícius Cotta-De-Almeida; Tania Araújo-Jorge
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Glycoinositolphospholipids from Trypanosoma cruzi induce B cell hyper-responsiveness in vivo.

Authors:  A M Bilate; J O Previato; L Mendonça-Previato; L M Peçanha
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

5.  NO contributes to proliferative suppression in a murine model of filariasis.

Authors:  R A O'Connor; J S Jenson; E Devaney
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

6.  Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cells.

Authors:  Christine A Petersen; Katherine A Krumholz; John Carmen; Anthony P Sinai; Barbara A Burleigh
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  Regulatory cells and immunosuppressive cytokines: parasite-derived factors induce immune polarization.

Authors:  Ali Ouaissi
Journal:  J Biomed Biotechnol       Date:  2007

8.  Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection.

Authors:  Marise Pinheiro Nunes; Bárbara Fortes; João Luiz Silva-Filho; Eugênia Terra-Granado; Leonardo Santos; Luciana Conde; Isadora de Araújo Oliveira; Leonardo Freire-de-Lima; Marina Vieira Martins; Ana Acacia Sá Pinheiro; Christina Maeda Takyia; Célio Geraldo Freire-de-Lima; Adriane Regina Todeschini; George Alexandre Dosreis; Alexandre Morrot
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

Review 9.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07

10.  A non-cytosolic protein of Trypanosoma evansi induces CD45-dependent lymphocyte death.

Authors:  Nicolas Antoine-Moussiaux; Anne Cornet; François Cornet; Stéphanie Glineur; Martin Dermine; Daniel Desmecht
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.